908 Devices Inc.
MASS908 Devices Inc. in brief
908 Devices Inc. is a listed company in the Medical Devices industry, based in Burlington, Massachusetts, USA. Its market value was $503 M on 14 October 2026, which makes it the 12,540th largest listed company in the world and the 2,532nd largest in the USA on this site. In the year to December 2025 it had sales of $56 M and a net profit of $19 M, about 35 cents of profit for every dollar of sales. It employs about 96 people and Kevin J. Knopp is its chief executive. Its largest product and service lines by sales in 2025 were Device sales revenue (65%), Recurring revenue (35%) and Contract revenue (under 1%). By market, the largest shares of its 2025 sales came from USA (73%), Europe, Middle East and Africa (19%) and Asia Pacific (5%). Its shares trade under the symbol MASS (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About 908 Devices Inc.
908 Devices is a chemical and biochemical analysis technology company that crosses industry boundaries, devices provide answers for critical to life questions in life science research, biopharmaceuticals, forensics and more. The company annual revenue is 26.8 million USD and total assets are 178.8 million USD as on 2020. The headquarters is in USA.
908 Devices Inc. timeline
- 2012
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2020
- 🔔Initial public offering on NasdaqFinal prospectus filed with the SEC on 18 December 2020; shares registered for exchange trading on 17 December 2020.
- 2025
- 💰Record revenue of $56 millionFY2025, the highest of the 6 years on record.
Events of 908 Devices Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,017 (Jan 2022) · #3,526 (Dec 2022) · #3,584 (Jul 2023) · #2,959 (Jan 2024) · #1,649 (Mar 2026) · #2,645 (Aug 2026) · #2,530 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 7.6×
- Price / book
- 3.5×
- Free cash flow yield
- -4.9%
- Net margin (TTM)
- -36.9%
- Operating margin
- -70.1%
- Return on equity
- -16.9%
- Liabilities / assets
- 24.4%
- Net debt
- $-173M
- Revenue growth
- +17.7%
- R&D / revenue
- 27.7%
- Revenue per employee
- $585 K
- Profit per employee
- $203 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $56M | +17.7% | $-39M | $19M | 34.7% |
| Dec 2024 | $48M | -4.9% | $-57M | $-72M | -151.2% |
| Dec 2023 | $50M | +7.2% | $-43M | $-36M | -72.5% |
| Dec 2022 | $47M | +11.0% | $-35M | $-34M | -71.6% |
| Dec 2021 | $42M | +57.0% | $-22M | $-22M | -52.5% |
| Dec 2020 | $27M | — | $-6M | $-13M | -47.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-24M | $1M | $-25M | $0.54 | — |
| Dec 2024 | $-30M | $1M | $-31M | $-2.12 | — |
| Dec 2023 | $-25M | $2M | $-27M | $-1.13 | — |
| Dec 2022 | $-21M | $2M | $-23M | $-1.07 | — |
| Dec 2021 | $-29M | $1M | $-30M | $-0.79 | — |
| Dec 2020 | $4M | $0M | $4M | $-2.35 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $19M (+35.4% on a year earlier), net income $-5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 10, 202610-QQuarterly report · period to Sep 2026
- Nov 10, 20268-KCurrent reportResults of operations
- Aug 11, 202610-QQuarterly report · period to Jun 2026
- Aug 11, 20268-KCurrent reportResults of operations
- Jul 8, 20268-KCurrent reportOther events
- Jun 12, 20268-KCurrent reportShareholder vote
- May 6, 202610-QQuarterly report · period to Mar 2026
- May 6, 20268-KCurrent reportMaterial agreement · Acquisition or disposal completed · Results of operations · Unregistered share sale · Regulation FD disclosure
- Apr 29, 2026DEF 14AProxy statement
- Mar 9, 202610-KAnnual report · period to Dec 2025
- Mar 3, 20268-KCurrent reportResults of operations
- Jan 20, 20268-KCurrent reportResults of operations
Official filings of 908 Devices Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $56 M
- Operating income
- $-39 M
- Net income
- $19 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $190 M
- Total liabilities
- $46 M
- Total equity
- $144 M
As of December-2025
Top 100 institutional investors in 908 Devices Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | First Light Asset Management, LLC | 6,641,149 | +358,345 (+5.70%) | 15.97% | $82 M | Nov 16, 2026 |
| 2 | ARCH Venture Management, LLC | 5,725,045 | New | 13.77% | $71 M | Nov 16, 2026 |
| 3 | AWM Investment Company, Inc. | 4,736,773 | -143,000 (-2.93%) | 11.39% | $58 M | Nov 13, 2026 |
| 4 | ARK Investment Management LLC | 2,094,832 | +66,912 (+3.30%) | 5.04% | $26 M | Nov 13, 2026 |
| 5 | BlackRock, Inc. | 2,045,156 | +100,920 (+5.19%) | 4.92% | $25 M | Nov 13, 2026 |
| 6 | Needham Investment Management LLC | 1,955,000 | +134,380 (+7.38%) | 4.70% | $24 M | Nov 16, 2026 |
| 7 | Vanguard Capital Management LLC | 1,324,267 | +32,697 (+2.53%) | 3.18% | $16 M | Nov 13, 2026 |
| 8 | American Century Companies Inc | 1,171,644 | +811,796 (+225.59%) | 2.82% | $14 M | Nov 12, 2026 |
| 9 | First Eagle Investment Management, LLC | 875,793 | -984,177 (-52.91%) | 2.11% | $11 M | Nov 10, 2026 |
| 10 | Geode Capital Management, LLC | 798,858 | +37,061 (+4.86%) | 1.92% | $10 M | Nov 6, 2026 |
| 11 | Lord, Abbett & Co. LLC | 688,494 | New | 1.66% | $8 M | Nov 13, 2026 |
| 12 | State Street Corp | 665,954 | +59,394 (+9.79%) | 1.60% | $8 M | Nov 12, 2026 |
| 13 | Granahan Investment Management, LLC | 516,655 | -175,437 (-25.35%) | 1.24% | $6 M | Nov 16, 2026 |
| 14 | Morgan Stanley | 511,907 | +107,829 (+26.69%) | 1.23% | $6 M | Nov 13, 2026 |
| 15 | Essex Investment Management Co LLC | 455,706 | -14,538 (-3.09%) | 1.10% | $6 M | Oct 19, 2026 |
| 16 | Prescott Group Capital Management, L.L.C. | 361,595 | 0 (0.00%) | 0.87% | $4 M | Oct 30, 2026 |
| 17 | HighMark Wealth Management LLC | 339,783 | 0 (0.00%) | 0.82% | $4 M | Nov 17, 2026 |
| 18 | Meros Investment Management, LP | 333,862 | -27,506 (-7.61%) | 0.80% | $4 M | Nov 17, 2026 |
| 19 | Renaissance Technologies LLC | 312,699 | +120,799 (+62.95%) | 0.75% | $4 M | Nov 12, 2026 |
| 20 | Charles Schwab Investment Management Inc | 287,304 | +53,412 (+22.84%) | 0.69% | $4 M | Nov 16, 2026 |
| 21 | Northern Trust Corp | 279,437 | +13,020 (+4.89%) | 0.67% | $3 M | Nov 16, 2026 |
| 22 | Acadian Asset Management LLC | 219,085 | +148,711 (+211.32%) | 0.53% | $3 M | Nov 9, 2026 |
| 23 | Vanguard Fiduciary Trust Co | 218,921 | +32,865 (+17.66%) | 0.53% | $3 M | Nov 13, 2026 |
| 24 | Vanguard Portfolio Management LLC | 215,336 | +20,478 (+10.51%) | 0.52% | $3 M | Nov 13, 2026 |
| 25 | Old Port Advisors | 213,364 | +174,735 (+452.34%) | 0.51% | $3 M | Oct 23, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Sumitomo Mitsui Trust Group, Inc. | 208,108 | -20,573 (-9.00%) | 0.50% | $3 M | Oct 29, 2026 |
| 27 | Amova Asset Management Americas, Inc. | 208,108 | -20,573 (-9.00%) | 0.50% | $3 M | Nov 13, 2026 |
| 28 | Dimensional Fund Advisors LP | 206,811 | +82,313 (+66.12%) | 0.50% | $3 M | Nov 4, 2026 |
| 29 | Raymond James Financial Inc | 160,874 | -6,474 (-3.87%) | 0.39% | $2 M | Nov 12, 2026 |
| 30 | D. E. Shaw & Co., Inc. | 160,064 | +84,618 (+112.16%) | 0.38% | $2 M | Nov 16, 2026 |
| 31 | Campbell & CO Investment Adviser LLC | 156,766 | +45,576 (+40.99%) | 0.38% | $2 M | Nov 13, 2026 |
| 32 | Victory Capital Management Inc | 155,816 | New | 0.37% | $2 M | Nov 10, 2026 |
| 33 | Cassaday & Co Wealth Management LLC | 146,466 | New | 0.35% | $2 M | Oct 27, 2026 |
| 34 | Nuveen, LLC | 143,450 | +1,723 (+1.22%) | 0.34% | $2 M | Nov 10, 2026 |
| 35 | Legato Capital Management LLC | 140,902 | -17,217 (-10.89%) | 0.34% | $2 M | Nov 10, 2026 |
| 36 | Perkins Capital Management Inc | 135,050 | New | 0.32% | $2 M | Nov 2, 2026 |
| 37 | AQR Capital Management LLC | 133,866 | +29,957 (+28.83%) | 0.32% | $2 M | Nov 16, 2026 |
| 38 | IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 120,509 | +21,820 (+22.11%) | 0.29% | $1 M | Nov 13, 2026 |
| 39 | Mitsubishi UFJ Asset Management Co., Ltd. | 115,169 | +4,612 (+4.17%) | 0.28% | $1 M | Nov 5, 2026 |
| 40 | Millennium Management LLC | 113,243 | New | 0.27% | $1 M | Nov 16, 2026 |
| 41 | Bank Of Montreal /can/ | 87,346 | 0 (0.00%) | 0.21% | $1 M | Nov 9, 2026 |
| 42 | SEI Investments Co | 77,719 | 0 (0.00%) | 0.19% | $1 M | Nov 10, 2026 |
| 43 | Bank of New York Mellon Corp | 75,832 | +3,074 (+4.22%) | 0.18% | $1 M | Nov 5, 2026 |
| 44 | Goldman Sachs Group Inc | 73,746 | -2,484 (-3.26%) | 0.18% | $1 M | Nov 16, 2026 |
| 45 | Squarepoint Ops LLC | 73,745 | +36,006 (+95.41%) | 0.18% | $1 M | Nov 9, 2026 |
| 46 | Bruce & Co., Inc. | 68,286 | 0 (0.00%) | 0.16% | $1 M | Nov 16, 2026 |
| 47 | Wealthspire Advisors, LLC | 67,302 | New | 0.16% | $1 M | Nov 13, 2026 |
| 48 | Qube Research & Technologies Ltd | 66,944 | New | 0.16% | $1 M | Nov 13, 2026 |
| 49 | Bank Of America Corp /de/ | 58,356 | -192,671 (-76.75%) | 0.14% | $1 M | Nov 16, 2026 |
| 50 | Citadel Advisors LLC | 55,754 | -6,993 (-11.14%) | 0.13% | $1 M | Nov 16, 2026 |
| 51 | Nano Cap New Millennium Growth Fund L P | 55,000 | -52,500 (-48.84%) | 0.13% | $1 M | Nov 13, 2026 |
| 52 | LPL Financial LLC | 54,967 | -484 (-0.87%) | 0.13% | $1 M | Nov 6, 2026 |
| 53 | Bridgeway Capital Management, LLC | 49,661 | -839 (-1.66%) | 0.12% | $1 M | Nov 16, 2026 |
| 54 | Empowered Funds, LLC | 49,661 | New | 0.12% | $1 M | Nov 13, 2026 |
| 55 | XTX Topco Ltd | 44,135 | New | 0.11% | $1 M | Nov 16, 2026 |
| 56 | Barclays PLC | 43,304 | +38,198 (+748.10%) | 0.10% | $1 M | Nov 6, 2026 |
| 57 | Trexquant Investment LP | 40,499 | New | 0.10% | $0 M | Nov 16, 2026 |
| 58 | Alliancebernstein L.P. | 39,550 | 0 (0.00%) | 0.10% | $0 M | Nov 16, 2026 |
| 59 | Quantinno Capital Management LP | 38,373 | +7,242 (+23.26%) | 0.09% | $0 M | Nov 13, 2026 |
| 60 | Susquehanna International Group, LLP | 36,791 | +13,417 (+57.40%) | 0.09% | $0 M | Nov 16, 2026 |
| 61 | Rhumbline Advisers | 36,544 | -247 (-0.67%) | 0.09% | $0 M | Nov 10, 2026 |
| 62 | UBS Group AG | 35,610 | -41,806 (-54.00%) | 0.09% | $0 M | Nov 10, 2026 |
| 63 | Deutsche Bank AG\ | 33,002 | +4,590 (+16.16%) | 0.08% | $0 M | Nov 6, 2026 |
| 64 | Pier 88 Investment Partners LLC | 22,600 | +8,400 (+59.15%) | 0.05% | $0 M | Nov 6, 2026 |
| 65 | Price T Rowe Associates Inc /MD/ | 22,120 | +1,733 (+8.50%) | 0.05% | $0 M | Nov 16, 2026 |
| 66 | FMR LLC | 19,697 | +298 (+1.54%) | 0.05% | $0 M | Nov 10, 2026 |
| 67 | Cresset Asset Management, LLC | 18,371 | +2,028 (+12.41%) | 0.04% | $0 M | Nov 16, 2026 |
| 68 | MetLife Investment Management, LLC | 17,292 | 0 (0.00%) | 0.04% | $0 M | Nov 16, 2026 |
| 69 | Jpmorgan Chase & Co | 15,821 | +3,262 (+25.97%) | 0.04% | $0 M | Nov 12, 2026 |
| 70 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 15,131 | +1,730 (+12.91%) | 0.04% | $0 M | Nov 16, 2026 |
| 71 | Invesco Ltd. | 14,813 | -147 (-0.98%) | 0.04% | $0 M | Nov 12, 2026 |
| 72 | 49 Wealth Management, LLC | 13,678 | New | 0.03% | $0 M | Nov 13, 2026 |
| 73 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13,653 | +12,117 (+788.87%) | 0.03% | $0 M | Nov 16, 2026 |
| 74 | Vanguard Global Advisers, LLC | 13,587 | +3,301 (+32.09%) | 0.03% | $0 M | Nov 13, 2026 |
| 75 | Brevan Howard Capital Management LP | 12,459 | -8,233 (-39.79%) | 0.03% | $0 M | Nov 16, 2026 |
| 76 | Concurrent Investment Advisors, LLC | 12,366 | +463 (+3.89%) | 0.03% | $0 M | Oct 16, 2026 |
| 77 | Gainline Financial Partners, LLC | 12,338 | 0 (0.00%) | 0.03% | $0 M | Oct 15, 2026 |
| 78 | Graham Capital Management, L.P. | 10,920 | -3,907 (-26.35%) | 0.03% | $0 M | Nov 16, 2026 |
| 79 | Wealth Enhancement Advisory Services, LLC | 10,324 | -1,001 (-8.84%) | 0.02% | $0 M | Oct 13, 2026 |
| 80 | Royal Bank Of Canada | 9,983 | +5,808 (+139.11%) | 0.02% | $0 M | Nov 16, 2026 |
| 81 | Russell Investments Group, Ltd. | 9,701 | -139,954 (-93.52%) | 0.02% | $0 M | Nov 6, 2026 |
| 82 | Police & Firemen's Retirement System of New Jersey | 8,523 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 83 | Wilmington Savings Fund Society, FSB | 8,500 | New | 0.02% | $0 M | Oct 23, 2026 |
| 84 | New York State Common Retirement Fund | 8,487 | 0 (0.00%) | 0.02% | $0 M | Nov 17, 2026 |
| 85 | BNP Paribas Financial Markets | 7,931 | +3,569 (+81.82%) | 0.02% | $0 M | Nov 12, 2026 |
| 86 | Citigroup Inc | 7,517 | -5,912 (-44.02%) | 0.02% | $0 M | Nov 4, 2026 |
| 87 | Wells Fargo & Company/mn | 6,145 | -18,227 (-74.79%) | 0.01% | $0 M | Nov 16, 2026 |
| 88 | ANTIPODES PARTNERS Ltd | 5,931 | +1,937 (+48.50%) | 0.01% | $0 M | Nov 5, 2026 |
| 89 | Tower Research Capital LLC (TRC) | 5,369 | +4,235 (+373.46%) | 0.01% | $0 M | Nov 16, 2026 |
| 90 | Osaic Holdings, Inc. | 4,837 | -788 (-14.01%) | 0.01% | $0 M | Nov 12, 2026 |
| 91 | Pinnacle Wealth Planning Services, Inc. | 4,180 | 0 (0.00%) | 0.01% | $0 M | Oct 27, 2026 |
| 92 | Legal & General Group Plc | 2,964 | -85 (-2.79%) | 0.01% | $0 M | Nov 16, 2026 |
| 93 | Ameritas Investment Partners, Inc. | 2,795 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 94 | Group One Trading LLC | 2,500 | New | 0.01% | $0 M | Nov 10, 2026 |
| 95 | Allworth Financial LP | 2,332 | -1,041 (-30.86%) | 0.01% | $0 M | Nov 17, 2026 |
| 96 | Signaturefd, LLC | 1,447 | 0 (0.00%) | 0.00% | $0 M | Oct 23, 2026 |
| 97 | GAMMA Investing LLC | 1,216 | +548 (+82.04%) | 0.00% | $0 M | Oct 8, 2026 |
| 98 | Versant Capital Management, Inc | 1,147 | +77 (+7.20%) | 0.00% | $0 M | Oct 2, 2026 |
| 99 | Arax Advisory Partners | 1,050 | +645 (+159.26%) | 0.00% | $0 M | Nov 12, 2026 |
| 100 | Jones Financial Companies Lllp | 1,048 | New | 0.00% | $0 M | Nov 13, 2026 |
Mutual funds holding 908 Devices Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 ARK Genomic Revolution ETFARK Investment Management LLC | 1.91 M | $15 M | 4.6% | 0.98% | −2.4% | Jul 31, 2026 |
| 🇺🇸 Needham Aggressive Growth FundNeedham Investment Management, LLC | 1.40 M | $12 M | 3.4% | 0.47% | +51% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 919,827 | $8 M | 2.2% | <0.01% | +18% | Jun 30, 2026 |
| 🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC | 860,882 | $7 M | 2.1% | 0.24% | +19% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 757,244 | $7 M | 1.8% | <0.01% | +8.3% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 340,050 | $3 M | 0.82% | <0.01% | +9.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 317,090 | $3 M | 0.76% | <0.01% | +16% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 261,667 | $2 M | 0.63% | 0.02% | +386% | Jun 30, 2026 |
| 🇺🇸 Needham Small Cap Growth FundNeedham Investment Management, LLC | 252,970 | $2 M | 0.61% | 0.53% | +111% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 144,417 | $1 M | 0.35% | <0.01% | +2.1% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 142,606 | $1 M | 0.34% | <0.01% | +5.5% | May 31, 2026 |
| 🇺🇸 Victory Small Cap Stock FundVictory Capital Management Inc. | 149,337 | $1 M | 0.36% | 0.12% | +0.6% | Jul 31, 2026 |
| 🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 131,062 | $1 M | 0.32% | <0.01% | −4.6% | May 31, 2026 |
| 🇺🇸 1290 Essex Small Cap Growth FundEquitable Investment Management, LLC | 113,551 | $1 M | 0.27% | 0.78% | no change | Jul 31, 2026 |
| 🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC | 100,953 | $1 M | 0.24% | 0.74% | — | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 97,794 | $1 M | 0.24% | 0.06% | +40% | Jun 30, 2026 |
| 🇺🇸 State Street SPDR S&P Kensho Future Security ETFSSGA Funds Management, Inc. | 85,312 | $1 M | 0.21% | 0.49% | −26% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust | 85,296 | $1 M | 0.21% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Bruce FundBruce and Company Inc | 68,286 | $1 M | 0.16% | 0.16% | no change | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 71,808 | $1 M | 0.17% | <0.01% | +19% | Jul 31, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 64,194 | $1 M | 0.15% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 53,796 | $0 M | 0.13% | <0.01% | +33% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 55,271 | $0 M | 0.13% | 0.02% | no change | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 50,500 | $0 M | 0.12% | 0.30% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 51,304 | $0 M | 0.12% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 40,718 | $0 M | 0.10% | 0.02% | +390% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 41,744 | $0 M | 0.10% | <0.01% | +6.7% | May 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 38,433 | $0 M | 0.09% | <0.01% | +27% | Jul 31, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 34,750 | $0 M | 0.08% | 0.02% | +10% | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 30,619 | $0 M | 0.07% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 30,370 | $0 M | 0.07% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 26,347 | $0 M | 0.06% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 20,330 | $0 M | 0.05% | <0.01% | +12% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 20,322 | $0 M | 0.05% | 0.01% | +3.0% | May 31, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 20,374 | $0 M | 0.05% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 18,100 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 15,916 | $0 M | 0.04% | <0.01% | +61% | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 15,777 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 15,131 | $0 M | 0.04% | <0.01% | +1.7% | Jun 30, 2026 |
| 🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc. | 15,500 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC | 14,522 | $0 M | 0.03% | 0.03% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 15,441 | $0 M | 0.04% | <0.01% | +12% | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 15,399 | $0 M | 0.04% | <0.01% | −31% | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 13,088 | $0 M | 0.03% | 0.05% | no change | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 13,918 | $0 M | 0.03% | <0.01% | +15% | Jul 31, 2026 |
| 🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc. | 10,903 | $0 M | 0.03% | 0.02% | −3.9% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 11,133 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC | 15,216 | $0 M | 0.04% | 0.06% | — | Mar 31, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 10,259 | $0 M | 0.02% | <0.01% | +2.7% | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 10,891 | $0 M | 0.03% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 9,400 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 9,272 | $0 M | 0.02% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 9,074 | $0 M | 0.02% | <0.01% | +51% | Jun 30, 2026 |
| 🇺🇸 Small-Cap Value PortfolioPacific Life Fund Advisors LLC | 8,167 | $0 M | 0.02% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 7,945 | $0 M | 0.02% | <0.01% | −0.8% | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 7,722 | $0 M | 0.02% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 6,488 | $0 M | 0.02% | 0.03% | +31% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 6,291 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 6,137 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 6,110 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 5,489 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 5,197 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 5,300 | $0 M | 0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 4,800 | $0 M | 0.01% | <0.01% | +200% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 4,885 | $0 M | 0.01% | <0.01% | +4.7% | May 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 4,698 | $0 M | 0.01% | <0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 4,431 | $0 M | 0.01% | <0.01% | +272% | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 4,373 | $0 M | 0.01% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 4,248 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 4,574 | $0 M | 0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP | 4,484 | $0 M | 0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 4,331 | $0 M | 0.01% | <0.01% | +4.4% | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 3,971 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 3,692 | $0 M | <0.01% | <0.01% | +37% | Jun 30, 2026 |
| 🇺🇸 Column Small Cap FundTrust for Professional Managers | 3,672 | $0 M | <0.01% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC | 3,185 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 3,263 | $0 M | <0.01% | <0.01% | +3.7% | Jul 31, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 3,169 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 3,049 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 2,795 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP | 2,993 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP | 2,718 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 2,606 | $0 M | <0.01% | <0.01% | +63% | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC | 2,289 | $0 M | <0.01% | 0.01% | +209% | Jun 30, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 2,268 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,190 | $0 M | <0.01% | <0.01% | +36% | Jun 30, 2026 |
| 🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC | 2,382 | $0 M | <0.01% | <0.01% | +773% | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 2,153 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 1,998 | $0 M | <0.01% | <0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 1,976 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 1,700 | $0 M | <0.01% | <0.01% | −5.5% | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP | 1,720 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 1,306 | $0 M | <0.01% | <0.01% | +10% | May 31, 2026 |
| 🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC | 1,268 | $0 M | <0.01% | <0.01% | +364% | Jun 30, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 1,181 | $0 M | <0.01% | <0.01% | −48% | Jun 30, 2026 |
| 🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP | 1,176 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 1,032 | $0 M | <0.01% | <0.01% | −39% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 1,020 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 903 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 821 | $0 M | <0.01% | <0.01% | −1.3% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at 908 Devices Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Christopher D. BrownDirector | Option exercise | +54,318 | $1.750 | $95 K | 829,877 | Form 4 |
| filed | Christopher D. BrownDirector | Sell10b5-1 plan | -30,000 | $10.95 | $329 K | 775,559 | Form 4 |
| filed | Christopher D. BrownDirector | Sell10b5-1 plan | -30,000 | $11.89 | $357 K | 745,559 | Form 4 |
| filed | Christopher D. BrownDirector | Option exercise10b5-1 plan | +60,000 | $1.750 | $105 K | 805,559 | Form 4 |
| filed | Joseph H. Griffith IVChief Financial Officer | Sell10b5-1 plan | -5,000 | $13.03 | $65 K | 116,497 | Form 4 |
| filed | AWM Investment Company, Inc.10% owner | Sellindirect | -18,000 | $11.52 | $207 K | 4.74 M | Form 4 |
| filed | AWM Investment Company, Inc.10% owner | Sellindirect | -24,000 | $11.36 | $273 K | 4.75 M | Form 4 |
| filed | AWM Investment Company, Inc.10% owner | Sellindirect | -1,000 | $11.25 | $11 K | 4.76 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: 908 Devices Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-03-04 12:25 UTC, code T3, resumed 13:00 UTC
Fails to deliver
- : 416 shares at $12.09
- : 835 shares at $12.33
- : 400 shares at $12.69
- : 1,020 shares at $11.85
- : 1,031 shares at $11.44
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
908 Devices Inc. scorecard#
Passes 10 of the 20 checks that could be worked out: strongest in growth (5 of 6), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 14, 2026.
Valuation0 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median3.5×Price to book 3.5× against Medical Devices's median of 2.5×.
- ✗Price to sales below its peers' median7.6×Price to sales 7.6× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%-4.9%Free cash flow is -4.9% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth5 of 6
- ✓Revenue grew in the newest year17.7%Revenue up 17.7% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years6.2%6.2% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median6.2%6.2% a year against Medical Devices's median of 10.8% (73 companies).
- ✓Earnings per share grew in the newest year0.54 vs -2.12Diluted EPS 0.54 in fiscal 2025 against -2.12 the year before (report's currency).
- ✓Net income higher than five years earlier$19 M$19 M in fiscal 2025 against -$13 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability3 of 5
- ✓Profitable in the newest year$19 MNet income $19 M in fiscal 2025.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-70.1%-70.1% against Medical Devices's median of -8.2% (86 companies).
- ✓Return on equity above 15%15.1%15.1% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-70.1%-70.1% in fiscal 2025 against -75.5% in 2022.
Financial health2 of 3
- ✓Short-term assets cover short-term liabilities4.2×Current ratio 4.24 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone5.17Z-score 5.17 (safe zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year5.3%Diluted shares up 5.3% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from 908 Devices Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -70.1% | -8.2% | |
| Net margin | 34.7% | -10.4% | |
| Return on equity | 15.1% | -16.8% | |
| Revenue growth, 3 years a year | 6.3% | 10.8% | |
| Revenue growth | 17.7% | 10.4% | |
| Free cash flow margin | -43.9% | -1.9% |
3of 8on the Piotroski tests of financial strength
- Free cash flow was negative: -$25 million.
- Only -122% of net income arrived as cash from operations.
- The share count rose 5.3% in the year.
908 Devices Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 56+17.7%100% | 48r60−4.9%100% | 50+7.2%100% | 47+11.0%100% | 42+56.9%100% | 27—100% | |
| Cost of revenue | 28+19.5%49.4% | 23r30−6.7%48.7% | 25+19.6%49.6% | 21+9.8%44.5% | 19+58.5%45.0% | 12—44.5% | |
| Gross profit | 28+16.0%50.6% | 25r30−3.2%51.3% | 25−2.7%50.4% | 26+12.0%55.5% | 23+55.7%55.0% | 15—55.5% | |
| Research and development | 16+3.9%27.7% | 15r25−31.6%31.4% | 22+25.0%43.6% | 18+34.1%37.4% | 13+58.7%31.0% | 8.2—30.6% | |
| Selling, general and administrative | 39−2.4%68.6% | 39r54−14.3%82.6% | 46r46+5.0%91.7% | 44+36.1%93.7% | 32+158%76.4% | 13—46.5% | |
| Operating expenses | 68−17.2%121% | 82r107+20.3%172% | 68+10.9%136% | 61+35.5%131% | 45+118%107% | 21—77.1% | |
| Operating income | −39—−70.1% | −57r−77—−120% | −43—−85.1% | −35—−75.5% | −22—−52.3% | −5.8—−21.6% | |
| Interest expense and finance costs | — | — | 0.2+55.8%0.4% | 0.1−73.5%0.3% | 0.5−50.2%1.2% | 1.0—3.6% | |
| Other non-operating income (expense) | 6.1+42.9%10.8% | 4.3r4.2−30.8%8.9% | 6.1+238%12.2% | 1.8—3.9% | −0.1—−0.2% | −7.0—−26.0% | |
| Income before tax | −33—−59.3% | −53r−72—−111% | −37—−72.9% | −34—−71.6% | — | — | |
| Income tax | −0.1—−0.1% | −0.3—−0.6% | −0.2—−0.4% | 0—0.0% | — | — | |
| Income from continuing operations | −33—−59.2% | −53—−111% | — | — | — | — | |
| Income from discontinued operations | 53—93.9% | −19—−39.9% | — | — | — | — | |
| Net income including minority interests | 19—34.7% | −72—−151% | −36—−72.5% | −34—−71.6% | −22—−52.5% | −13—−47.7% | |
| Net income attributable to shareholders | 19—34.7% | −72—−151% | −36—−72.5% | −34—−71.6% | −22—−52.5% | −13—−47.7% | |
| Earnings per share, basic | 0.54—— | -2.12—— | -1.13—— | -1.07—— | -0.79—— | -2.35—— | |
| Earnings per share, diluted | 0.54—— | -2.12—— | -1.13—— | -1.07—— | -0.79—— | -2.35—— | |
| Shares, weighted average (basic) | 36+5.3%— | 34+5.7%— | 32+2.4%— | 31+12.6%— | 28+410%— | 5.5—— | |
| Shares, weighted average (diluted) | 36+5.3%— | 34+5.7%— | 32+2.4%— | 31+12.6%— | 28+410%— | 5.5—— | |
| Balance sheet | |||||||
| Cash and cash equivalents | 71+60.1%37.1% | 44r44−63.6%27.6% | 121−35.8%59.6% | 188−15.9%77.7% | 224+40.7%85.9% | 159—89.0% | |
| Short-term investments | 42+66.0%22.3% | 26+3.8%16.0% | 25—12.1% | 0—0.0% | — | — | |
| Receivables | 11+28.0%6.0% | 8.9r13−1.5%5.6% | 9.0−10.4%4.4% | 10−38.7%4.1% | 16+140%6.3% | 6.8—3.8% | |
| Inventory | 13+19.3%6.8% | 11r16−27.1%6.8% | 15+19.4%7.4% | 13+58.0%5.2% | 7.9+73.3%3.0% | 4.6—2.6% | |
| Other current assets | 7.3+73.8%3.8% | 4.2r4.7+0.1%2.6% | 4.2−10.2%2.1% | 4.7+2.9%1.9% | 4.5+1205%1.7% | 0.3r0.3—0.2% | |
| Current assets | 145+40.3%76.1% | 103−40.7%64.6% | 174−19.4%85.6% | 216−14.7%88.9% | 253+47.9%96.9% | 171—95.6% | |
| Property, plant and equipment | 4.2+165%2.2% | 1.6r3.4−52.3%1.0% | 3.3+8.4%1.6% | 3.1+92.3%1.3% | 1.6+88.6%0.6% | 0.9—0.5% | |
| Right-of-use (leased) assets | 4.4+14.4%2.3% | 3.8r6.9−38.4%2.4% | 6.2+57.6%3.1% | 4.0−23.7%1.6% | 5.2−17.6%2.0% | 6.3—3.5% | |
| Goodwill | 0—0.0% | 0−100%0.0% | 10+3.2%5.1% | 10—4.1% | — | — | |
| Other intangible assets | 36−5.9%19.2% | 39r45+392%24.3% | 7.9−7.4%3.9% | 8.5—3.5% | — | — | |
| Total assets | 190+19.2%100% | 159−21.4%100% | 203−16.3%100% | 243−7.0%100% | 261+45.9%100% | 179—100% | |
| Accounts payable | 1.6+15.9%0.8% | 1.4r2.1+14.9%0.9% | 1.2−14.7%0.6% | 1.4+1.9%0.6% | 1.4+36.6%0.5% | 1.0—0.6% | |
| Debt due within a year | — | — | — | — | — | 0.5—0.3% | |
| Current liabilities | 34+35.4%17.9% | 25+11.5%15.8% | 23+17.3%11.1% | 19+29.6%7.9% | 15+37.0%5.7% | 11—6.1% | |
| Long-term debt | — | — | — | 150.0%6.2% | 15+4.7%5.7% | 14—8.0% | |
| Lease liabilities (non-current) | 3.9+51.8%2.1% | 2.6r4.7−33.8%1.6% | 3.9+29.2%1.9% | 3.0−32.6%1.3% | 4.5−22.8%1.7% | 5.8—3.3% | |
| Total liabilities | 46+3.3%24.4% | 45+19.7%28.1% | 37−27.9%18.5% | 52+12.3%21.4% | 46+16.4%17.7% | 40—22.2% | |
| Retained earnings | −223—−117% | −243—−152% | −171—−84.0% | −134—−55.3% | −101—−38.6% | −78—−43.9% | |
| Shareholders' equity | 144+25.4%75.6% | 115−30.8%71.9% | 165−13.2%81.5% | 191−11.2%78.6% | 215+54.3%82.3% | 139—77.8% | |
| Total liabilities and equity | 190+19.2%100% | 159−21.4%100% | 203−16.3%100% | 243−7.0%100% | 261+45.9%100% | 179—100% | |
| Shares outstanding | 36+3.5%— | 35+7.9%— | 33+2.1%— | 32+2.5%— | 31+13.9%— | 27—— | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 4.5−4.6%7.9% | 4.7+96.4%9.8% | 2.4+47.7%4.7% | 1.6+74.5%3.4% | 0.9+11.3%2.2% | 0.8—3.1% | |
| Share-based compensation | 9.8−16.3%17.5% | 12+20.2%24.6% | 9.8+35.8%19.5% | 7.2+188%15.4% | 2.5+377%5.9% | 0.5—2.0% | |
| Cash from operating activities | −24—−42.2% | −30—−63.3% | −25—−49.9% | −21—−44.7% | −29−804%−68.9% | 4.1—15.4% | |
| Capital expenditure | −1.0—−1.7% | −0.6—−1.3% | −2.0—−4.1% | −2.0—−4.4% | −0.7—−1.7% | −0.0—−0.0% | |
| Acquisitions, net of cash acquired | — | — | — | −14—−29.4% | — | — | |
| Cash from investing activities | 51—90.3% | −46—−97.0% | −26—−52.6% | −16—−33.7% | −0.7—−1.7% | −0.0—−0.0% | |
| Cash from financing activities | −0.7—−1.2% | −0.4—−0.8% | −16−1452%−31.7% | 1.2−98.8%2.5% | 95−31.0%224% | 137—510% | |
| Exchange-rate effect on cash | 0.0—0.0% | −0.1−600%−0.1% | 0.0−27.8%0.0% | 0.0—0.0% | — | — | |
| Change in cash | 26—47.0% | −77—−161% | −67—−134% | −36−155%−75.9% | 65−54.1%154% | 141—525% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 66+23.7%100% | 19+35.3%100% | 16+23.3%100% | 13+13.6%100% | 17*+21.2%100% | 14−3.5%100% | 13+13.7%100% | 12+58.7%100% | 14r19*−0.1%100% | 15r17—100% | 11r14—100% | 7.4r10.0—100% | 14*—100% | |
| Cost of revenue | 31+15.3%47.7% | 8.9+34.3%47.1% | 7.7+16.0%48.1% | 6.5+4.2%48.6% | 8.2*+7.2%47.3% | 6.7−1.3%47.5% | 6.7+25.7%51.1% | 6.2+76.4%53.0% | 7.7r9.7*+8.4%53.5% | 6.7r8.4—46.4% | 5.3r6.6—46.2% | 3.5r5.0—47.6% | 7.1*—49.3% | |
| Gross profit | 34+32.6%52.3% | 10+36.2%52.9% | 8.3+30.9%51.9% | 6.9+24.2%51.4% | 9.2*+37.2%52.7% | 7.4−5.4%52.5% | 6.4+3.4%48.9% | 5.5+42.6%47.0% | 6.7r9.1*−8.3%46.5% | 7.8r8.3—53.6% | 6.2r7.4—53.8% | 3.9r5.0—52.4% | 7.3*—50.7% | |
| Research and development | 14−9.9%21.9% | 3.8−0.5%20.2% | 3.6−18.3%22.4% | 3.5−9.3%25.9% | 3.5*−10.2%20.2% | 3.8−8.8%27.4% | 4.4+22.7%33.8% | 3.8+16.3%32.5% | 3.9r6.5*−28.4%27.2% | 4.2r6.8—29.0% | 3.6r6.4—31.3% | 3.3r5.8—44.4% | 5.4*—37.9% | |
| Selling, general and administrative | 42+4.1%63.6% | 12+31.2%63.2% | 11+7.5%69.1% | 9.9−3.2%74.1% | 8.8*−15.7%50.7% | 9.1−5.7%65.2% | 10−7.0%79.3% | 10+24.8%86.9% | 10r14*−11.1%72.9% | 9.7r13—66.7% | 11r15—96.9% | 8.2r12—111% | 12r12*—82.0% | |
| Operating expenses | 62−26.7%95.0% | 15−34.6%81.8% | 21−1.8%132% | 20+19.3%148% | 6.1*−74.1%34.9% | 24−26.6%169% | 22+46.5%165% | 17+44.1%141% | 23r29*+37.9%163% | 32r39—222% | 15r21—128% | 11r18—155% | 17*—118% | |
| Operating income | −28—−42.7% | −5.5—−28.9% | −13—−79.7% | −13—−96.3% | 3.1*—17.8% | −16—−117% | −15—−116% | −11—−93.6% | −17r−20*—−117% | −24r−30—−169% | −8.5r−14—−74.5% | −7.6r−13—−103% | −9.7*—−67.7% | |
| Interest expense and finance costs | — | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | |
| Other non-operating income (expense) | 3.8−33.8%5.7% | 0.8−41.2%4.5% | 0.9−63.0%5.4% | 0.9−21.9%6.9% | 1.1*+54.5%6.4% | 1.4+70.6%10.3% | 2.3+141%17.8% | 1.2−30.7%10.1% | 0.7r0.7*−68.2%5.1% | 0.8r0.9—5.8% | 1.0r0.9—8.4% | 1.7r1.7—23.1% | 2.3*—15.9% | |
| Income before tax | — | −4.6—−24.4% | −12—−74.3% | — | 4.2*—24.2% | −15—−106% | −13—−98.5% | — | −16r−20*—−112% | −24r−29—−163% | −7.6r−13—−66.1% | −11—−148% | −7.4*—−51.8% | |
| Income tax | — | −0.1−272%−0.3% | −0.1−176%−0.3% | — | −0.2*—−1.0% | 0.0—0.2% | 0.1—0.5% | — | −0.1*—−0.5% | −0.1—−0.5% | −0.1—−0.6% | −0.1—−0.9% | −0.0*—−0.0% | |
| Income from continuing operations | −24—−36.6% | −4.6—−24.2% | −12—−74.0% | −12—−89.3% | 4.4*—25.2% | −15—−106% | −13—−99.0% | −9.8—−83.5% | −16*—−112% | −24—−163% | −7.6—−66.1% | −5.9—−79.4% | — | |
| Income from discontinued operations | — | — | — | — | −0.2*—−1.2% | −0.1—−0.5% | −0.4—−3.1% | 53—454% | −3.4*—−23.9% | −5.6—−38.9% | −5.0—−43.4% | −5.0—−67.7% | — | |
| Net income including minority interests | −24—−36.9% | −4.6*—−24.2% | −12*—−74.0% | −12−127%−89.3% | 4.2*—24.0% | −15*—−107% | −13*—−102% | 44—370% | −19*—−136% | −29*—−202% | −13*—−109% | −11—−147% | −7.4*—−51.8% | |
| Net income attributable to shareholders | −24—−36.9% | −4.6—−24.2% | −12—−74.0% | −12−127%−89.3% | 4.2*—24.0% | −15—−107% | −13—−102% | 44—370% | −19*—−136% | −29—−202% | −13—−109% | −11—−147% | −7.4*—−51.8% | |
| Earnings per share, basic | — | -0.11—— | -0.32—— | -0.32−126%— | — | -0.41—— | -0.37—— | 1.23—— | — | -0.84—— | -0.37—— | -0.33—— | — | |
| Earnings per share, diluted | — | -0.11—— | -0.32—— | -0.32−126%— | — | -0.41—— | -0.37—— | 1.23—— | — | -0.84—— | -0.37—— | -0.33—— | — | |
| Shares, weighted average (basic) | 41+13.8%— | 41+13.8%— | 38+5.2%— | 37+4.0%— | — | 36+4.1%— | 36+5.3%— | 35+8.2%— | — | 35—— | 34—— | 33—— | — | |
| Shares, weighted average (diluted) | 41+13.8%— | 41+13.8%— | 38+5.2%— | 37+4.0%— | — | 36+4.1%— | 36+5.3%— | 35+8.2%— | — | 35—— | 34—— | 33—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 64—31.9% | 64+1.3%31.9% | 63+2.1%31.9% | 68−14.7%36.2% | 71+60.1%37.1% | 63+39.5%32.9% | 62+31.9%32.2% | 79−24.3%40.4% | 44r44−63.6%27.6% | 45—25.3% | 47—22.4% | 105—55.1% | 121—59.6% | |
| Short-term investments | 36—17.8% | 36−27.9%17.8% | 39−32.2%19.5% | 44−2.2%23.7% | 42+66.0%22.3% | 49+84.7%25.8% | 57+85.9%29.6% | 45+52.6%23.0% | 26+3.8%16.0% | 27—15.0% | 31—14.6% | 30—15.6% | 25—12.1% | |
| Receivables | 17—8.6% | 17+56.5%8.6% | 12+88.7%5.9% | 9.9+42.4%5.3% | 11+28.0%6.0% | 11−34.0%5.8% | 6.2−43.5%3.2% | 6.9−7.4%3.5% | 8.9r13−1.5%5.6% | 17—9.3% | 11—5.3% | 7.5—3.9% | 9.0—4.4% | |
| Inventory | 15—7.4% | 15−4.1%7.4% | 14−7.0%7.3% | 13+3.9%7.1% | 13+19.3%6.8% | 15−14.1%8.0% | 15−16.8%8.1% | 13−22.1%6.5% | 11r16−27.1%6.8% | 18—10.0% | 19—8.9% | 16—8.6% | 15—7.4% | |
| Other current assets | 4.1—2.1% | 4.1−37.3%2.1% | 4.4−42.1%2.2% | 7.2+42.7%3.8% | 7.3+73.8%3.8% | 6.6+139%3.4% | 7.6+118%4.0% | 5.0+31.1%2.6% | 4.2r4.7+0.1%2.6% | 2.7—1.5% | 3.5—1.7% | 3.8—2.0% | 4.2—2.1% | |
| Current assets | 135—67.8% | 135−6.8%67.8% | 132−10.7%66.8% | 142−4.7%76.1% | 145+40.3%76.1% | 145+33.1%75.9% | 148+33.9%77.1% | 149−7.9%76.0% | 103−40.7%64.6% | 109—61.1% | 110—52.9% | 162—85.3% | 174—85.6% | |
| Property, plant and equipment | 4.4—2.2% | 4.4+7.1%2.2% | 4.6+179%2.3% | 4.1+174%2.2% | 4.2+165%2.2% | 4.1+13.1%2.2% | 1.7−53.5%0.9% | 1.5−53.1%0.8% | 1.6r3.4−52.3%1.0% | 3.7—2.1% | 3.6—1.7% | 3.2—1.7% | 3.3—1.6% | |
| Right-of-use (leased) assets | 4.7—2.4% | 4.7+13.9%2.4% | 4.0−6.6%2.0% | 4.2+17.7%2.3% | 4.4+14.4%2.3% | 4.2−44.5%2.2% | 4.3+616%2.2% | 3.6−37.9%1.8% | 3.8r6.9−38.4%2.4% | 7.5—4.2% | 0.6r5.9—0.3% | 5.8—3.0% | 6.2—3.1% | |
| Goodwill | 10—5.1% | 10—5.1% | 11—5.6% | — | 0—0.0% | — | — | — | 0−100%0.0% | 10—5.7% | 40—19.3% | 10—5.3% | 10—5.1% | |
| Other intangible assets | 44—22.1% | 44+18.6%22.1% | 45+21.1%22.8% | 36−6.0%19.1% | 36−5.9%19.2% | 37−20.4%19.5% | 37−21.2%19.4% | 38+408%19.4% | 39r45+392%24.3% | 47—26.2% | 47—22.7% | 7.5—3.9% | 7.9—3.9% | |
| Total assets | 199—100% | 199+4.4%100% | 198+3.0%100% | 187−4.8%100% | 190+19.2%100% | 191+7.1%100% | 192−8.2%100% | 196+3.3%100% | 159−21.4%100% | 178—100% | 209—100% | 190—100% | 203—100% | |
| Accounts payable | 2.8—1.4% | 2.8+52.3%1.4% | 2.7−24.4%1.4% | 2.4−37.2%1.3% | 1.6+15.9%0.8% | 1.8−4.4%0.9% | 3.6+81.6%1.9% | 3.8+161%2.0% | 1.4r2.1+14.9%0.9% | 1.9—1.1% | 2.0—0.9% | 1.5—0.8% | 1.2—0.6% | |
| Current liabilities | 25—12.5% | 25−40.0%12.5% | 49+66.4%25.0% | 40+103%21.2% | 34+35.4%17.9% | 41+61.3%21.7% | 30+36.8%15.5% | 20+1.2%10.0% | 25+11.5%15.8% | 26—14.4% | 22—10.4% | 19—10.2% | 23—11.1% | |
| Lease liabilities (non-current) | 4.4—2.2% | 4.4+12.8%2.2% | 3.6−10.4%1.8% | 3.8+38.8%2.0% | 3.9+51.8%2.1% | 3.9−20.7%2.0% | 4.0+16.3%2.1% | 2.7−19.7%1.4% | 2.6r4.7−33.8%1.6% | 4.9—2.7% | 3.4—1.6% | 3.4—1.8% | 3.9—1.9% | |
| Total liabilities | 50—24.9% | 50−9.2%24.9% | 71+65.0%35.8% | 53+43.5%28.1% | 46+3.3%24.4% | 55+15.5%28.6% | 43−18.2%22.4% | 37+11.3%18.7% | 45+19.7%28.1% | 47—26.5% | 52—25.1% | 33—17.3% | 37—18.5% | |
| Retained earnings | −252—−126% | −252—−126% | −247—−125% | −235—−126% | −223—−117% | −227—−119% | −213—−111% | −199—−102% | −243—−152% | −223—−125% | −194—−93.0% | −182—−95.6% | −171—−84.0% | |
| Shareholders' equity | 150—75.1% | 150+9.9%75.1% | 127−14.8%64.2% | 134−15.8%71.9% | 144+25.4%75.6% | 136+4.0%71.4% | 149−4.8%77.6% | 159+1.6%81.3% | 115−30.8%71.9% | 131—73.5% | 156—74.9% | 157—82.7% | 165—81.5% | |
| Total liabilities and equity | 199—100% | 199+4.4%100% | 198+3.0%100% | 187−4.8%100% | 190+19.2%100% | 191+7.1%100% | 192−8.2%100% | 196+3.3%100% | 159−21.4%100% | 178—100% | 209—100% | 190—100% | 203—100% | |
| Shares outstanding | 41—— | 41+14.7%— | 38+5.6%— | 37+4.7%— | 36+3.5%— | 36+4.1%— | 36+4.1%— | 36+8.6%— | 35+7.9%— | 35—— | 35—— | 33—— | 33—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 5.1+6.7%7.8% | 1.5*+37.7%7.9% | 1.4*+40.0%8.5% | 1.1−11.8%8.5% | 1.1*−22.7%6.4% | 1.1*−22.8%7.8% | 1.0*+92.9%7.5% | 1.3−2.8%11.0% | 1.4*+255%10.0% | 1.4*—9.7% | 0.5*—4.4% | 1.3—17.9% | 0.4*—2.8% | |
| Share-based compensation | 9.8−0.9%14.9% | 2.3−1.8%12.3% | 2.3−1.0%14.4% | 2.4+1.4%17.9% | 2.8*−2.1%15.9% | 2.4+3.4%17.0% | 2.3+4.8%17.9% | 2.4−10.5%20.1% | 2.8*+20.8%19.7% | 2.3r3.2—15.8% | 2.2r3.1—19.4% | 2.6—35.6% | 2.3*—16.3% | |
| Cash from operating activities | 2.9—4.4% | −2.8*—−14.8% | 3.2*—19.7% | 1.2—9.0% | 1.3*—7.6% | −4.2*—−30.0% | −5.8*—−44.4% | −15—−128% | −2.2*—−15.6% | −5.6*—−38.6% | −13*—−114% | −9.4—−126% | −1.9*—−13.4% | |
| Capital expenditure | — | −0.1*—−0.3% | −0.2*—−1.0% | −0.0—−0.3% | — | −0.7*—−4.9% | −0.1*—−0.9% | −0.2—−1.4% | −0.2*—−1.3% | −0.2*—−1.1% | — | −0.9—−12.2% | −0.3*—−2.3% | |
| Cash from investing activities | 0.4−99.0%0.7% | 2.9*−43.4%15.6% | −7.3*—−45.5% | −2.0−104%−14.9% | 6.8*+773%39.2% | 5.2*+37.5%37.2% | −12*—−88.9% | 50—427% | 0.8*−83.2%5.4% | 3.8*—26.1% | −45*—−394% | −5.8—−77.9% | 4.6*—32.3% | |
| Cash from financing activities | −1.1−549%−1.7% | 0.5*—2.7% | 1.0*—6.0% | −2.2—−16.2% | −0.4*−178%−2.4% | −0.0*−170%−0.1% | −0.1*−121%−0.6% | −0.2—−1.6% | 0.5*+457%3.7% | 0.0*—0.2% | 0.4*—3.2% | −1.3—−17.4% | 0.1*—0.7% | |
| Exchange-rate effect on cash | — | −0.0*—−0.2% | — | — | 0*—0.0% | 0*−100%0.0% | 0*—0.0% | 0.0—0.2% | −0.1*−319%−0.4% | 0.0*—0.1% | −0.0*—−0.0% | −0.0—−0.1% | 0.0*—0.2% | |
| Change in cash | 2.1−88.0%3.2% | 0.6*−39.3%3.2% | −3.2*—−20.1% | −3.0−108%−22.1% | 7.7*—44.4% | 1.0*—7.1% | −17*—−134% | 35—298% | −1.0*−135%−6.9% | −1.8*—−12.3% | −58*—−504% | −16—−222% | 2.8*—19.7% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What 908 Devices Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Product revenue(total)$43 M77%+22%
- Device sales revenue$37 M65%+16%
- Recurring revenue$19 M35%+22%
- Service revenue(total)$13 M23%+5.7%
- Contract revenue$0 M0.2%-7.7%
Business segments
- Single reportable segment$56 M100%+18%
Countries and regions
- 🇺🇸 USA$41 M73%+16%
- Europe, Middle East and Africa$10 M19%+14%
- Asia Pacific$3 M5.3%+43%
- Americas other$2 M2.7%+77%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at 908 Devices Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Kevin J. Knopp, Ph.D. was our PEO for both years presented. | $1.6 M | $3.0 M | $1.2 M | $47 |
| 2024Kevin J. Knopp | $2.0 M | $29 K | $1.2 M | $20 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at 908 Devices Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Acquisition or sale completed 3 · Directors and officers 3 · Material agreement 3 · Unregistered share sale 2 · Shareholder vote 3 · Results announced 13
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Acquisition or sale completedMaterial agreementUnregistered share saleResults announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Acquisition or sale completedMaterial agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Acquisition or sale completedMaterial agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026
Acquisitions and funding#
2 acquisitions, $72 M paid where reported · 5 private funding rounds before listing
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| KAF Manufacturing Company | 2025 | — | $3 M | — | Annual report |
| Red Wave | 2024 | — | $69 M | — | Annual report |
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2019 | $18 M | No. 5 | $10 to $50 million | 12 | equity | SEC |
| Mar 2017 | $24 M | No. 4 | $10 to $50 million | 13 | equity | SEC |
| Apr 2015 | $12 M | No. 3 | $10 to $50 million | 8 | equity | SEC |
| Aug 2013 | $7 M | No. 2 | $2 to $10 million | 7 | equity | SEC |
| Jun 2012 | $8 M | No. 1 | $2 to $10 million | 4 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Lobbying by 908 Devices Inc.#
$290 K spent on lobbying the US Congress and federal agencies in 2025, most often on budget/appropriations, homeland security and defense.
- Budget/Appropriations8 reports
- Homeland Security7 reports
- Defense7 reports
- Law Enforcement/Crime/Criminal Justice7 reports
Lobbying firms hired in 2025
National Group, LLP $200 K · Brendan Neal Strategies, LLC $90 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $218 K | — | 6 |
| 2025 | $290 K | — | 8 |
| 2024 | $265 K | — | 8 |
| 2023 | $200 K | — | 8 |
| 2022 | $200 K | — | 8 |
| 2021 | $80 K | — | 5 |
| 2019 | $50 K | — | 2 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “908 Devices, Inc.”, “908 Devices Inc” and “National Group LLP on Behalf of 908 Devices (fka 908 Devices, Inc.)”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
Discuss 908 Devices Inc.#
3 automatic updates and 0 member comments. Sign in to comment and react.
- Results announced on 10 November 2026automatic update · Nov 10, 2026
908 Devices Inc. announced results on 10 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $19 million (up 35% from a year earlier) and a net loss of $5 million.
- Insider trading in October 2026automatic update · Oct 31, 2026
Directors and officers of 908 Devices Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $421,850 in 2 trades. Awards, option exercises and shares withheld for tax are not counted.
- Mutual funds: 105 funds hold $77 millionautomatic update · Jul 31, 2026
105 mutual funds in 1 country hold shares of 908 Devices Inc. worth $77 million, about 22.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 53 funds added shares and 17 sold; on balance they bought $11 million. Share splits are not counted as trading.
How 908 Devices Inc. compares in Medical Devices
- Market cap$503 M · higher than 50% of 142
- Revenue$56 M · higher than 29% of 155
- Net margin-36.9% · higher than 29% of 144
- Revenue growth17.7% · higher than 68% of 104
- Price / sales7.6× · lower than 22% of 96
- Price / book3.5× · lower than 41% of 99
- FCF yield-4.9% · higher than 40% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| 908 Devices Inc.🇺🇸 | $503 M | — | -36.9% | +17.7% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Delcath Systems, Inc.$500 M
- NeuroPace, Inc.$487 M
- AK Medical Holdings Limited$537 M
- Tactile Systems Technology, Inc.$545 M
- Sight Sciences, Inc.$448 M
- OrthoPediatrics Corp.$573 M
Sources and freshness
- Market cap:
- Oct 14, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on September 2020
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at 908 Devices Inc.? Verify and update this profile — free
Show 908 Devices Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.